published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt
..: "fremanezumab for the preventive treatment of chronic migraine.".
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..